Shigellosis in day care centers: use of plasmid analysis to assess control measures.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 6344045)

Published in Pediatr Infect Dis on July 08, 1983

Authors

C O Tacket, M L Cohen

Articles citing this

Analysis of clonal relationships among isolates of Shigella sonnei by different molecular typing methods. J Clin Microbiol (1995) 2.28

Molecular epidemiology of Shigella infections: plasmid profiles, serotype correlation, and restriction endonuclease analysis. J Clin Microbiol (1991) 1.99

Restriction fragment length polymorphisms in rRNA operons for subtyping Shigella sonnei. J Clin Microbiol (1991) 1.63

Usefulness of plasmid profiles for differentiation of Shigella isolates in Bangladesh. J Clin Microbiol (1984) 1.61

Evaluation of the molecular epidemiology of an outbreak of multiply resistant Shigella sonnei in a day-care center by using pulsed-field gel electrophoresis and plasmid DNA analysis. J Clin Microbiol (1993) 1.26

Control of day care shigellosis: a trial of convalescent day care in isolation. Am J Public Health (1986) 1.15

Use of multiple markers for investigation of an epidemic of Shigella sonnei infections in Monroe County, New York. J Clin Microbiol (1991) 1.14

Interventions for the control of diarrhoeal diseases among young children: chemoprophylaxis. Bull World Health Organ (1985) 1.03

Characterization of endemic Shigella flexneri strains in Somalia: antimicrobial resistance, plasmid profiles, and serotype correlation. J Clin Microbiol (1994) 0.98

Epidemic spread of Shigella sonnei shigellosis and evidence for development of immunity among children attending day-care centers in a communal settlement (Kibbutz). J Clin Microbiol (1994) 0.90

Temporal shifts in the dominance of serotypes of Shigella dysenteriae from 1999 to 2002 in Dhaka, Bangladesh. J Clin Microbiol (2003) 0.87

Plasmid profile analysis and antimicrobial susceptibility patterns of Shigella isolates from Nigeria. Epidemiol Infect (1990) 0.83

Controlled trial of Giardia lamblia: control strategies in day care centers. Am J Public Health (1991) 0.81

Articles by these authors

Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72

Boron nitride nanotubes. Science (1995) 5.53

Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J Clin Invest (1993) 4.53

Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet (1988) 4.12

Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect Immun (1987) 3.96

Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection. Ann Intern Med (1982) 3.95

Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann Intern Med (1984) 3.88

A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun (1987) 3.76

Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis (1984) 3.69

Comparison of plasmid profile analysis, phage typing, and antimicrobial susceptibility testing in characterizing Salmonella typhimurium isolates from outbreaks. J Clin Microbiol (1984) 3.33

Drug-resistant Salmonella from animals fed antimicrobials. N Engl J Med (1984) 3.26

Drug-resistant Salmonella in the United States: an epidemiologic perspective. Science (1986) 3.16

Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers. J Infect Dis (1995) 3.14

Emerging foodborne diseases. Emerg Infect Dis (1997) 3.05

High-molecular-weight plasmid correlates with Escherichia coli enteroinvasiveness. Infect Immun (1982) 2.95

Fungal infections: a growing threat. Public Health Rep (1996) 2.59

Cloned, random chromosomal sequences as probes to identify Salmonella species. J Infect Dis (1986) 2.58

Prediction of new low compressibility solids. Science (1989) 2.46

Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg (2000) 2.39

Career interruptions and hours practiced: comparison between young men and women physicians. Can J Public Health (1990) 2.37

Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microb Drug Resist (2000) 2.29

Common R-plasmids in Staphylococcus aureus and Staphylococcus epidermidis during a nosocomial Staphylococcus aureus outbreak. Antimicrob Agents Chemother (1982) 2.27

Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study. JAMA (1988) 2.26

Protein antigens from Staphylococcus aureus strains associated with toxic-shock syndrome. Science (1981) 2.25

Distribution and three-dimensional structure of intercellular junctions in canine myocardium. Circ Res (1989) 2.25

Vibrio cholerae O1 can assume a chlorine-resistant rugose survival form that is virulent for humans. J Infect Dis (1996) 2.17

Illness caused by Vibrio damsela and Vibrio hollisae. Lancet (1982) 2.17

Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis (1994) 2.03

On the cerebral accumulation of ketamine and the relationship between metabolism of the drug and its pharmacological effects. J Pharmacol Exp Ther (1974) 1.97

Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med (1984) 1.96

Purification, morphology, and genetics of a new fimbrial putative colonization factor of enterotoxigenic Escherichia coli O159:H4. Infect Immun (1987) 1.86

Animal-to-man transmission of antimicrobial-resistant Salmonella: investigations of U.S. outbreaks, 1971-1983. Science (1984) 1.85

Evaluation of isolated cases of salmonellosis by plasmid profile analysis: introduction and transmission of a bacterial clone by precooked roast beef. J Infect Dis (1983) 1.81

Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives. Infect Immun (1990) 1.80

Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers. J Infect Dis (1995) 1.75

Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiology (1973) 1.74

Epidemic salmonellosis from cheddar cheese: surveillance and prevention. Am J Epidemiol (1980) 1.72

Decreased vascular relaxation in hypertension. J Pharmacol Exp Ther (1976) 1.72

Food poisoning due to Clostridium perfringens in the United States. J Infect Dis (1983) 1.70

Animal models to study Escherichia coli O157:H7 isolated from patients with haemorrhagic colitis. Lancet (1983) 1.70

A multistate outbreak of infections caused by Yersinia enterocolitica transmitted by pasteurized milk. JAMA (1984) 1.70

Nosocomial Legionnaires' disease: a continuing common-source epidemic at Wadsworth Medical Center. Ann Intern Med (1979) 1.66

Acute intermittent porphyria: clinicopathologic correlation. Report of a case and review of the literature. Neurology (1997) 1.64

An assessment of patient-related economic costs in an outbreak of salmonellosis. N Engl J Med (1978) 1.63

Usefulness of plasmid profiles for differentiation of Shigella isolates in Bangladesh. J Clin Microbiol (1984) 1.61

New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae. Infect Immun (1996) 1.58

Diarrhea associated with Vibrio fluvialis in the United States. J Clin Microbiol (1982) 1.57

Turtle-associated salmonellosis in the United States. Effect of Public Health Action, 1970 to 1976. JAMA (1980) 1.56

The incidence and natural history of pericardial effusion after cardiac surgery--an echocardiographic study. Circulation (1984) 1.55

Spinal anaesthesia induced by intrathecal magnesium sulphate. Anaesthesia (1996) 1.54

Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol (1993) 1.54

Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected]. J Infect Dis (1991) 1.53

Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease. Science (1988) 1.51

Progress in vaccines against typhoid fever. Rev Infect Dis (1989) 1.49

Rapid group A streptococcal antigen detection kit: effect on antimicrobial therapy for acute pharyngitis. Pediatrics (1988) 1.49

Spinal anaesthesia with midazolam in the rat. Can J Anaesth (1997) 1.49

The design and conduct of clinical trials to limit missing data. Stat Med (2012) 1.48

Intracranial Wegener's granulomatosis. Neurology (1993) 1.47

Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS (1990) 1.46

Self-esteem in children medically managed for attention deficit disorder. Pediatrics (1989) 1.43

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. J Infect Dis (1994) 1.43

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med (1991) 1.43

M(2) and M(4) receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro. J Pharmacol Exp Ther (2000) 1.40

Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J Clin Invest (1992) 1.39

Sporadic community-acquired Legionnaires' disease in the United States. A case-control study. Ann Intern Med (1979) 1.37

Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle. J Pharmacol Exp Ther (1981) 1.37

Serological responses of patients with lepromatous and tuberculoid leprosy to 30-, 31-, and 32-kilodalton antigens of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.36

Host-Salmonella interaction: human trials. Microbes Infect (2001) 1.35

Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J Infect Dis (1986) 1.35

Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J Infect Dis (1998) 1.34

Measurement of the thermal properties of human skin. A review. J Invest Dermatol (1977) 1.34

Changes in antimicrobial resistance of Salmonella isolated from humans in the United States. JAMA (1987) 1.34

Toxic shock syndrome: modification and comparison of methods for detecting marker proteins in Staphylococcus aureus. J Clin Microbiol (1983) 1.34

Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination. J Virol (1993) 1.33

Utilization of salivary concentrations of ciprofloxacin in subjects with cystic fibrosis. Infection (1997) 1.32

Sterile, caseous mitral anular abscess. J Am Coll Cardiol (1983) 1.32

Editorials: Updating sphygmomanometry. Am J Cardiol (1974) 1.31

Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model. Infect Immun (1985) 1.30

Hantavirus pulmonary syndrome: an emerging infectious disease. Science (1993) 1.28

Water-related disease outbreaks in the United States, 1981. J Infect Dis (1983) 1.27

Chylothorax: diagnosis by lipoprotein electrophoresis of serum and pleural fluid. Thorax (1977) 1.24

Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge. Infect Immun (1998) 1.23

Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun (1998) 1.23

Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity. Clin Diagn Lab Immunol (1997) 1.23

Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus. Mol Pharmacol (1992) 1.22

Botulism and botulism-like illness in chronic drug abusers. Ann Intern Med (1985) 1.21

The changing epidemiology of adult botulism in the United States. Am J Epidemiol (1986) 1.21

Wound infections caused by Vibrio vulnificus, a marine vibrio, in inland areas of the United States. J Clin Microbiol (1984) 1.20

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. J Infect Dis (1994) 1.19

Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci (2000) 1.19

Importance of host factors in human salmonellosis caused by multiresistant strains of Salmonella. J Infect Dis (1984) 1.19

In vitro relaxation of arteries and veins by prazosin: alpha-adrenergic blockade with no direct vasodilation. Blood Vessels (1979) 1.15

A voluntary serosurvey and behavioral risk assessment for human immunodeficiency virus infection among college students. Sex Transm Dis (1992) 1.15

Unusual responses to electrocutaneous stimulation in refractory cervicobrachial pain: clues to a neuropathic pathogenesis. Clin Exp Rheumatol (1993) 1.15

Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle. J Pharmacol Exp Ther (1985) 1.13

Referred pain of peripheral nerve origin: an alternative to the "myofascial pain" construct. Clin J Pain (1994) 1.13

Fatal nosocomial Legionnaires' disease: clinical and epidemiologic characteristics. Ann Intern Med (1979) 1.13

Radiation-induced cerebral meningioma: a recognizable entity. J Neurosurg (1984) 1.12